Compare Peptides
Select any two compounds for a side-by-side comparison of mechanism, uses, risks, and FDA regulatory status.
Popular comparisons
A synthetic analog of parathyroid hormone-related protein (PTHrP) FDA-approved for osteoporosis. Similar to teriparatide but with a potentially more favorable bone-building to bone-resorbing ratio and lower hypercalcemia risk.
Bioactive peptide fragments derived from hydrolyzed collagen protein. The most commercially successful peptide supplement category, with a global market exceeding $5 billion. Available in Types I, II, III, and marine-sourced variants.
Selectively activates the RG conformation of the PTH1 receptor, producing a more transient signaling response than teriparatide. This results in robust bone formation with less bone resorption and less calcium mobilization from bone.
Provides bioavailable proline, glycine, and hydroxyproline — amino acids critical for collagen synthesis. Dipeptides (Pro-Hyp, Hyp-Gly) are absorbed intact and stimulate fibroblast activity, promoting endogenous collagen production in skin, joints, and connective tissue.
- Postmenopausal osteoporosis
- Fracture risk reduction
- Bone density improvement
- Skin elasticity and hydration
- Joint health and mobility
- Hair and nail strength
- Gut lining support
- Bone density support
- Osteosarcoma risk (boxed warning — animal studies)
- Dizziness
- Nausea
- Tachycardia
- Injection site reactions
- Limited to 2 years of use
- Generally well-tolerated
- Mild GI discomfort in some users
- Allergic reactions (rare, especially marine-sourced)
- Heavy metal contamination risk in low-quality products
- Efficacy debated — some studies industry-funded
FDA-approved as Tymlos (2017) for treatment of postmenopausal women with osteoporosis at high fracture risk. Limited to 2 years. Pen injector for daily self-administration.
Classified as a dietary supplement under DSHEA. Not FDA-approved for any medical indication. Widely available OTC without prescription. No regulatory restrictions.
This comparison is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide therapy.